Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostate cancer cells. [electronic resource]
Producer: 20130827Description: e58267 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspases -- genetics
- Cell Cycle Checkpoints -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase Inhibitor p21 -- antagonists & inhibitors
- Gene Expression Regulation, Neoplastic -- drug effects
- Histone Deacetylase Inhibitors -- pharmacology
- Histones -- antagonists & inhibitors
- Humans
- Hydroxamic Acids -- pharmacology
- Male
- Mice
- Mice, Nude
- Prostatic Neoplasms -- drug therapy
- Tumor Burden -- drug effects
- Vorinostat
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.